UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Nissen, M J; Ciurea, A; Bernhard, J; Tamborrini, G; Mueller, R; Weiss, B; Toniolo, M; Exer, P; Finckh, A (2016). The effect of comedication with a conventional synthetic disease-modifying antirheumatic drug on drug retention and clinical effectiveness of anti-tumor necrosis factor therapy in patients with axial spondyloarthritis. Arthritis and Rheumatology, 68(9):2141-2150.

Niedermann, K; Forster, A; Ciurea, A; Hammond, A; Uebelhart, D; de Bie, R (2011). Development and psychometric properties of a joint protection self-efficacy scale. Scandinavian Journal of Occupational Therapy, 18(2):143-152.

Niedermann, K; de Bie, R A; Kubli, R; Ciurea, A; Steurer-Stey, C; Villiger, P M; Büchi, S (2011). Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial. Patient Education and Counseling, 82(1):42-48.

Niedermann, K; Buchi, S; Ciurea, A; Kubli, R; Steurer-Stey, C; Villiger, P M; de Bie, R A (2011). Six and 12 months' effects of individual joint protection education in people with rheumatoid arthritis: A randomized controlled trial. Scandinavian Journal of Occupational Therapy:1-10.

Finckh, A; Ciurea, A; Brulhart, L; Möller, B; Walker, U A; Courvoisier, D; Kyburz, D; Dudler, J; Gabay, C (2010). Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent? Annals of the Rheumatic Diseases, 69(2):387-393.

Strobel, K; Fischer, D R; Tamborrini, G; Kyburz, D; Stumpe, K D M; Hesselmann, R G X; Johayem, A; von Schulthess, G K; Michel, B A; Ciurea, A (2010). 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. European Journal of Nuclear Medicine and Molecular Imaging, 37(9):1760-1765.

Finckh, A; Dudler, J; Wermelinger, F; Ciurea, A; Kyburz, D; Gabay, C; Bas, S (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint, Bone, Spine, 77(4):313-318.

Du Pan, S M; Dehler, S; Ciurea, A; Ziswiler, H R; Gabay, C; Finckh, A (2009). Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis and Rheumatism, 61(5):560-568.

Mertens, J C; Kaplan, V; Ciurea, A (2008). Diagnostik und Therapie der Rheumatoiden Arthritis. Praxis, 97(23):1211-1218.

Finckh, A; Ciurea, A; Brulhart, L; Kyburz, D; Möller, B; Dehler, S; Revaz, S; Dudler, J; Gabay, C (2007). B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents. Arthritis and Rheumatism, 56(5):1417-1723.

This list was generated on Sun Jul 23 19:14:31 2017 CEST.